Evaluating the Prevalence of Clinical and Paraclinical Findings in Hospitalized Children with The Disseminated Infection Caused by BCG Vaccine in The Pediatric Ward of Ali Ibn Abi Talib Hospital

Gholamreza Soleimani, Farnoosh Hosseini Shahidi


Introduction and objective: Tuberculosis is an infectious disease with global spread and BCG vaccine is the only vaccine available against this disease. The disseminated infection caused by the BCG vaccine is a rare, but dangerous complication of this vaccine. This study was conducted with the aim of evaluating the prevalence of clinical and paraclinical findings in hospitalized children with the disseminated infection caused by BCG vaccine in the pediatric ward of Ali ibn Abi Talib Hospital in 2015. Materials and methods: In this descriptive study, the files of all children who were hospitalized in the pediatric ward of Ali ibn Abi Talib Hospital in Zahedan with the diagnosis of the disseminated infection caused by the BCG vaccine during the years 2011-2015 were selected as census and they were examined. Six files were excluded from the study due to a lack of information. Information about the clinical and laboratory findings of the patients was extracted from the files. Descriptive information was displayed using SPSS ver.21 software. Findings: The files of 27 children were studied in this study; 16 children (59.3%) were boys and 11 children (40.7%) were girls. The most common clinical findings included fever in 23 patients (85.2%), lymphadenopathy in 20 patients (74.1%), weight loss in 15 patients (55.6%), hepatomegaly in 4 patients (14.8%), and splenomegaly in 4 patients (14.8%). The most common hematological findings were anemia and leukocytosis. Discussion and Conclusion: According to the results of this study, the diagnosis of the disseminated infection caused by BCG vaccine should be considered in all newborns and children with fever, lymphadenopathy, hepatosplenomegaly, any abnormal hematologic or radiological findings, and the history of BCG vaccine inoculation.


BCG vaccine, Tuberculosis, Children

Full Text:



Dr. Maryam Seif Hashemi et al. Study of Complications of BCG Vaccine in Semnan Children. Iranian Children's Diseases Journal. Volume 15, Issue 3, Autumn 2005.

WHO. Treatment of tuberculosis: guidelines.Geneve,Switzerland:WHOPress; 2010.

Incidence of tuberculosis in Iran. Ministry of Health and Medical Education. Center for Disease Control. Available from: http://www.cdc.hbi.ir/ Accessed January December 26, 2010.

Moghtaderi A, Alavi-Naini R, Rahimi-Movaghar V. Tuberculous myelopathy: current aspects of neurologic sequels in the southeast of Iran. Acta Neurol Scand 2006;113:267–272

Fitzgerald D, Sterling T, Haas D. Mandell G, Benett J, Dolin R. Mandell, Douglas, and Bennetts principles and practice of infectious diseases. 7th ed. Philadelphia: Churchill Livingstone/ Elsevier; 2010.

Bani Fazl, Mohammad, Ramezani, Amitis, Babaei Moghaddam, Mohammad Reza. "TB disease textbook". Tehran: Poursina Publishing House, 2002.

Trevenen CL, Paqtakhan RD. Disseminated tuberculoid lesions in infants following BCG vaccination. Can Med Assos J 1988;127(6):502-4.

Penelope HD, Georges Peter. Active immunizing agents. In: feigin, Cherry, Demmler. Kaplan’s text book of pediatric infectious diseases. 5th ed. Philadelphia: Saunders; 2004.

Szczua L. Adverse events following immunization with BCG vaccine in Poland 1994-2000. Przegl Epidemiol 2oo2:56(2):205-16.

Casanova JL, Blanche S, Emile Jf. Jouanguy E, Bordigoni P, Lambamedi S, et al. Idiopathic disseminated Bacillus calmette – Güerin infection: A French National retrospective study. Pediatrics 1996;98(4):774-8.

Lotte A, Wasz-Hockert O, Poisson N, Dumitrescu N, Verron M, Couvet E. BCG complications: estimates for the risks among vaccinated sub- jects and statistical analysis of their main characteristics. Adv Tuberc Res 1994;2:107–93.

Levin M, Newport MJ, D'Souza S, Kalabalikis P, Brown IN, Lenicker HM, et al. Familial disseminated atypical mycobacterial infection in childhood: a human mycobacrurid susceptibility gene. Lancet 1995;345:79-83.

Afshar Paiman SH, Siadati A, Mamishi S, Tabatabaie P, Khotaee GH. Disseminated Mycobacterium bovis Inط÷fection after BCG Vaccination. Iran J Allergy Asthma Immunol 2006;5(3):133-137.

Torriani R, Zimmermann A, Morel A. BCG sepsis as a total complication of BCG vaccination. Schweiz Med Wochenschr 1979;109(19):708-15.

Kumar PV, Banuni SA. Fine needle aspiration findings in generalized post-Calmette-Guerin bacillus lymphadenitis presenting as an abdominal mass. Acta Cytol 1994;38(2):165-8.

Karimi, Abdullah; Nateghian, AliReza; Memoshi, Star. "A report of 8 cases of diffuse tuberculosis due to inoculation of BCZ vaccine at the Tehran Children's Medical Center during the years of 80-76". Journal of Mazandaran University of Medical Sciences, vol 13, no. 38, 2003.

Edeer Karaca N, Boisson-Dupuis S, Aksu G, Bustamante J, Kandiloglu G, Ozsan N, et al. Granulomatous skin lesions, severe scrotal and lower limb edema due to mycobacterial infections in a child with complete IFN-γ receptor-1 deficiency. Immunotherapy 2012; 4(11): 1121-7.

Munoz FM, Starke JJR. Tuberculosis. In: Behrman RE, Kliegman M, Jensen B: Nelson Textbook of Pediatrics. 17th ed. Philadelphia: Saunders; 2004.

Strake J, Smith M. Tuberculosis. In: Feigin & Cherry’s textbook of pediatrics infectious disease. 4th ed. Saunders Company; 1998.

Davidson P, Genshemier K, Melius J, et al. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. CDC weekly report and recommendation. 1996;26(45):1-18.

Talbu EA, Perkins MD, Silva SF, Forthingham R. Disseminated bacille Calmette-Guerin disease after vaccination: case report and review. Clin Infect Dis. 1997;24(6):1139-46.

Babac S, Franulvic J. Familial libility to complication after BCG vaccination. Acta Padiatry. 1997;86(8):899-903.

Gantzer A, Neven B, Picard C, Brousse N, Lortholary O, Fraitag S, et al. Severe cutaneous bacillus Calmette-Guérin infection in immunocompromised children: the relevance of skin biopsy. J Cutan Pathol 2013;40(1):30-7.

Shahmohammadi SH, Saffar MJ, Rezai MS. BCG-osis after BCG vaccination in immunocompromised children: Case series and review. J Pediatr Rev 2014;2(1):47-54.

Galal N, Boutros J, Marsafy A, Kong XF, Feinberg J, Casanova JL, et al. Mendelian susceptibility to mycobacterial disease in egyptian children. Mediterr J Hematol Infect Dis 2012;4(1):e2012033.

Jadali F, Karimi A, Armin SH, Gharib A, Fallah A, Sharifian M. Detection of Disseminated Mycobactrial Infection Due to BCG Vaccination (BCGosis) in 4 Suspected Infant Autopsies by PCR Method. Iranian Journal of Pathology 2007;2(3):89- 93.


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Revista Publicando.

Licencia de Creative Commons


This Content is available under licencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional.